China's Pharmaceutical Distribution Market Reaches 1.54 Trillion RMB in First Half of 2026, Up 4%
In the first half of 2026, China's pharmaceutical distribution industry recorded a market size of about 1.54 trillion RMB, up approximately 4% year on year, as the sector accelerated its transformation toward intensification and specialization. High-end cold chain logistics became a profit growth point, with leading enterprises deploying multi-temperature zone smart warehouses nationwide. As digital and intelligent transformation became increasingly common, AI scheduling, unmanned warehouses, and full-chain temperature and humidity tracking became standard.
Why this event matters
The event has a measured impact on 6 industrys. The strongest current signal is positive for Pharmaceuticals, with intensity 60/100 and 80% confidence over a short term horizon.
Pharmaceuticals
- Direction
- positive
- Intensity
- 60
- Confidence
- 80%
- Horizon
- Short term
Logistics & Express Delivery
- Direction
- positive
- Intensity
- 55
- Confidence
- 75%
- Horizon
- Short term
Biotechnology
- Direction
- positive
- Intensity
- 55
- Confidence
- 70%
- Horizon
- Short term
Traditional Chinese Medicine
- Direction
- positive
- Intensity
- 50
- Confidence
- 75%
- Horizon
- Short term
Medical Consumables
- Direction
- positive
- Intensity
- 50
- Confidence
- 75%
- Horizon
- Short term
Medical Equipment
- Direction
- positive
- Intensity
- 50
- Confidence
- 70%
- Horizon
- Short term
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.